Sphenopalatine Ganglion Block for Postdural Puncture Headache
NCT ID: NCT04892290
Last Updated: 2021-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
110 participants
OBSERVATIONAL
2019-12-01
2020-05-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: Evaluating the effectiveness of topical SGB on PDPH treatment. Design: Retrospective observational study Setting: Single center tertiary level of care hospital study. The files of PDPH patients between Jan 2018 and Jan 2020 were scanned.
Patients: PDPH patients aged 18-65 are included and any patients with primary/secondary headache history are excluded.
Main outcome measures: Patients were divided into 2 groups. The group that given only conservative treatment was named as Group C, and the group of patients who had additionally been applied SGB was named as Group SGB. Headache severity was measured with Visual Analogue Scale (VAS) at the 1st,3rd, 12th and 24th hours of the treatment, in supine and upright position.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
NCT02181205
Trans-nasal Sphenopalatine Ganglion Block Versus Ultrasound-guided Bilateral Greater and Lesser Occipital Nerve Block for Management of Post-Dural Puncture Headache.
NCT06705244
Sphenopalatine Block or Epidural Bloodpatch for Post Dural Puncture Headache: Randomized Controlled Trial
NCT02984618
Bilateral Sphenopalatine Ganglion Block With or Without Bilateral Greater Occipital Nerve Block for Treatment of Obstetric Post-Dural Puncture Headache
NCT04844229
Sphenopalatine Ganglion Block for Post-Dural Puncture Headache in Orthopedic Patients
NCT04657952
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group C
Postdural puncture headache patients treated with Conservative treatment
Conservative Treatment for Postdural Puncture Headache
The patients in Group C were given continuous bed rest in the supine position, 3000 mL daily hydration, 6 mg kg-1 aminophylline , 2 g day-1 paracetamol and 65 mg day-1 caffeine as conservative treatment. Topical SGB was applied to patients in Group SGB in addition to conservative treatment.
Group SGB
Postdural puncture headache patients treated with Sphenopalatine Ganglion Block and conservative treatment
Conservative Treatment for Postdural Puncture Headache
The patients in Group C were given continuous bed rest in the supine position, 3000 mL daily hydration, 6 mg kg-1 aminophylline , 2 g day-1 paracetamol and 65 mg day-1 caffeine as conservative treatment. Topical SGB was applied to patients in Group SGB in addition to conservative treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Conservative Treatment for Postdural Puncture Headache
The patients in Group C were given continuous bed rest in the supine position, 3000 mL daily hydration, 6 mg kg-1 aminophylline , 2 g day-1 paracetamol and 65 mg day-1 caffeine as conservative treatment. Topical SGB was applied to patients in Group SGB in addition to conservative treatment.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* not having any headache diagnosis (G44 and subgroup according to the International Classification of Diseases-10 classification),
* developed PDPH according to the International Headaches Classification after the neuraxial procedure
Exclusion Criteria
* secondary headache such as preeclampsia / eclampsia, cerebral venous thrombosis, stroke, ruptured aneurysm, hypertensive encephalopathy, pituitary apoplexy, meningitis and subarachnoid hemorrhage
* any local or systemic infection
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sakarya University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Burak Kaya
Anesthesiology and Reanimation Specialist, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Burak Kaya, MD
Role: PRINCIPAL_INVESTIGATOR
Sakarya University
Serbülent Gökhan Beyaz, Prof MD
Role: STUDY_CHAIR
Istinye University
Ayça Taş Tuna, As Prof MD
Role: STUDY_CHAIR
Sakarya University
Havva Kocayiğit, MD
Role: STUDY_CHAIR
Sakarya University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sakarya University Training and Research Hospital
Sakarya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
71522473/050.01.04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.